| Primary |
| Vertigo |
23.0% |
| Hypertension |
11.2% |
| Dizziness |
10.5% |
| Meniere's Disease |
6.6% |
| Balance Disorder |
5.9% |
| Emphysema |
5.9% |
| Anticoagulant Therapy |
3.9% |
| Chronic Obstructive Pulmonary Disease |
3.9% |
| Head Injury |
3.9% |
| Thyroid Disorder |
3.3% |
| Anxiety |
2.6% |
| Blood Cholesterol Increased |
2.6% |
| Convulsion |
2.6% |
| Alcoholism |
2.0% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Hormone Level Abnormal |
2.0% |
| Hypersensitivity |
2.0% |
| Inner Ear Disorder |
2.0% |
| Mallory-weiss Syndrome |
2.0% |
| Neuritis |
2.0% |
|
| Drug Ineffective |
16.9% |
| Dizziness |
11.3% |
| Somnolence |
9.9% |
| Drug Hypersensitivity |
7.0% |
| Hypersensitivity |
5.6% |
| Coronary Artery Bypass |
4.2% |
| Fatigue |
4.2% |
| Feeling Abnormal |
4.2% |
| Malaise |
4.2% |
| Therapeutic Response Unexpected |
4.2% |
| Asthenia |
2.8% |
| Balance Disorder |
2.8% |
| Blood Cholesterol Abnormal |
2.8% |
| Expired Drug Administered |
2.8% |
| Headache |
2.8% |
| Hypothyroidism |
2.8% |
| No Adverse Event |
2.8% |
| Ulcer |
2.8% |
| Vertigo |
2.8% |
| Vestibular Disorder |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
14.7% |
| Dizziness |
12.1% |
| Hypertension |
10.8% |
| Vertigo |
9.1% |
| Foetal Exposure During Pregnancy |
7.3% |
| Emphysema |
6.5% |
| Anticoagulant Therapy |
4.3% |
| Balance Disorder |
4.3% |
| Convulsion |
3.9% |
| Migraine |
3.0% |
| Chronic Obstructive Pulmonary Disease |
2.6% |
| Coronary Artery Bypass |
2.6% |
| Grand Mal Convulsion |
2.6% |
| Head Injury |
2.6% |
| Neuropathy Peripheral |
2.6% |
| Pain |
2.6% |
| Alcoholism |
2.2% |
| Diabetes Mellitus |
2.2% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Pollakiuria |
2.2% |
|
| Coronary Artery Bypass |
11.4% |
| Vertigo |
11.4% |
| Somnolence |
9.1% |
| Drug Ineffective |
6.8% |
| Visual Impairment |
6.8% |
| Blood Pressure Fluctuation |
4.5% |
| Cerebrovascular Accident |
4.5% |
| Dizziness |
4.5% |
| Drug Hypersensitivity |
4.5% |
| Hypersensitivity |
4.5% |
| Malaise |
4.5% |
| Rash |
4.5% |
| Stress |
4.5% |
| Weight Increased |
4.5% |
| Abdominal Discomfort |
2.3% |
| Abnormal Behaviour |
2.3% |
| Adverse Event |
2.3% |
| Angioplasty |
2.3% |
| Arterial Occlusive Disease |
2.3% |
| Arthralgia |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.9% |
| Drug Use For Unknown Indication |
10.3% |
| Pain |
9.6% |
| Hypertension |
7.2% |
| Multiple Sclerosis |
6.2% |
| Gastrooesophageal Reflux Disease |
5.4% |
| Dizziness |
4.7% |
| Vertigo |
4.6% |
| Nausea |
3.8% |
| Depression |
3.3% |
| Rheumatoid Arthritis |
3.1% |
| Anxiety |
3.0% |
| Diabetes Mellitus |
2.9% |
| Insomnia |
2.4% |
| Prophylaxis |
2.3% |
| Hypothyroidism |
2.1% |
| Sleep Disorder |
2.1% |
| Asthma |
2.1% |
| Osteoporosis |
2.1% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
|
| Vomiting |
13.7% |
| Urinary Tract Infection |
12.3% |
| Vision Blurred |
6.7% |
| Pain In Extremity |
6.3% |
| Weight Decreased |
6.0% |
| Vertigo |
5.3% |
| Dizziness |
4.9% |
| Death |
4.6% |
| Myocardial Infarction |
4.6% |
| Wound |
4.6% |
| Electrolyte Imbalance |
3.5% |
| Nausea |
3.5% |
| Weight Increased |
3.5% |
| Convulsion |
3.2% |
| Tremor |
3.2% |
| Visual Impairment |
3.2% |
| Drug Ineffective |
2.8% |
| Electrocardiogram Qt Prolonged |
2.8% |
| Pneumonia |
2.8% |
| Therapeutic Agent Toxicity |
2.8% |
|
